25 Oct 2017 --- Biological solutions giant Novozymes has published its “solid” results for the nine months of 2017, which also shows strong growth for Q3. The growth is greater than expected, according to company CEO Peder Holk Nielsen, who also said that the company is adjusting the outlook for the full-year upwards. The third quarter saw organic revenue growth of 8 percent and 4 percent over the nine months, bolstered by a strong Food & Beverages category which was up 9 percent.